Conjunctival diseases: Conjunctivitis. Etiology. Classification. Diagnostics. Treatment. Dystrophic diseases of the conjunctiva.

Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive material from Kanski's Clinical Ophthalmology covering all topics. Let me compose the full answer.

Conjunctival Diseases: Conjunctivitis and Dystrophic Conditions

Based primarily on Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Edition

ANATOMY OF THE CONJUNCTIVA

The conjunctiva is a transparent mucous membrane lining the inner surface of the eyelids and the anterior surface of the globe, terminating at the corneoscleral limbus. It is divided into:
  • Palpebral conjunctiva — firmly attached to the posterior tarsal plates
  • Fornical conjunctiva — loose and redundant
  • Bulbar conjunctiva — covers the anterior sclera; continuous with corneal epithelium at the limbus
Histology: Non-keratinizing stratified squamous epithelium (~5 cells deep) with mucus-secreting goblet cells (densest inferonasally and in the fornices). The stroma contains accessory lacrimal glands of Krause and Wolfring. Conjunctiva-associated lymphoid tissue (CALT) mediates ocular surface immunity.

CONJUNCTIVITIS

Clinical Features of Conjunctival Inflammation

Symptoms (non-specific): lacrimation, grittiness, stinging, burning. Itching is the hallmark of allergic disease. Significant pain, photophobia, or foreign body sensation suggests corneal involvement.
Discharge character is diagnostically important:
Discharge TypeTypical Cause
Watery/serousAcute viral or acute allergic
MucoidChronic allergic conjunctivitis, dry eye
MucopurulentChlamydial or acute bacterial
Moderately purulentAcute bacterial
Severe/hyperacute purulentGonococcal infection
Conjunctival reaction types:
  • Hyperaemia — diffuse, beefy-red, more intense away from the limbus; suggests infectious/toxic etiology
  • Follicles — small, avascular, elevated lesions with a pale center surrounded by vessels; seen in viral, chlamydial, and toxic conjunctivitis
  • Papillae — vascularized elevations with a central fibrovascular core; seen in bacterial and allergic conjunctivitis
  • Chemosis — conjunctival oedema
  • Membrane/pseudomembrane — fibrinous exudate on the tarsal surface; seen in severe bacterial (GAS), adenoviral EKC, and toxic reactions

CLASSIFICATION AND ETIOLOGY

1. Bacterial Conjunctivitis

Acute Bacterial Conjunctivitis

Etiology: Most common isolates:
  • Streptococcus pneumoniae
  • Staphylococcus aureus
  • Haemophilus influenzae
  • Moraxella catarrhalis
  • Neisseria gonorrhoeae (severe/hyperacute — can penetrate intact corneal epithelium)
  • Neisseria meningitidis (rare, mainly children)
Clinical features:
  • Acute onset of redness, grittiness, burning, discharge
  • Usually bilateral (second eye involved 1–2 days later)
  • Eyelids stuck together on waking
  • Discharge: initially watery → rapidly mucopurulent
  • Hyperacute purulent discharge → suspect gonococcal/meningococcal
  • Superficial punctate epithelial erosions
  • Peripheral corneal ulceration possible with gonococcal/meningococcal infection
Investigations (not routine; indicated in severe cases):
  • Conjunctival swabs + scrapings for Gram stain (Gram-negative intracellular diplococci → gonococcus)
  • Culture on chocolate agar or Thayer-Martin medium for N. gonorrhoeae
  • PCR for cases failing treatment (to rule out chlamydial/viral)
Treatment:
  • Most cases are self-limiting (~60% resolve in 1–2 weeks without treatment)
  • Topical broad-spectrum antibiotics (chloramphenicol, fusidic acid, quinolones) reduce duration
  • Gonococcal conjunctivitis: topical antibiotic + systemic ceftriaxone (third-generation cephalosporin); saline irrigation; co-treat for Chlamydia
  • Good hygiene; do not share towels; hand washing

Adult Chlamydial (Inclusion) Conjunctivitis

Etiology: Chlamydia trachomatis serovars D–K. Affects 5–20% of sexually active young adults; spread by autoinoculation from genital secretions (~90%) or eye-to-eye contact (~10%). Incubation ~1 week.
Clinical features:
  • Subacute onset of unilateral or bilateral redness, watering, discharge
  • Tender preauricular lymphadenopathy
  • Large follicles prominent in the inferior fornix
  • Superficial punctate keratitis; perilimbal subepithelial corneal infiltrates (after 2–3 weeks)
  • Mild conjunctival scarring and superior corneal pannus in chronic cases
  • Genital symptoms (urethritis, discharge) often present
Investigations:
  • Tarsal conjunctival scrapings: Giemsa stain (basophilic intracytoplasmic inclusion bodies)
  • PCR/NAAT (nucleic acid amplification test) — most sensitive
  • Direct immunofluorescence (~90% sensitivity), enzyme immunoassay
Treatment:
  • Systemic treatment is essential to eradicate the genital reservoir
  • Azithromycin 1 g single dose (first choice)
  • Doxycycline 100 mg twice daily × 7–14 days (alternative)
  • Erythromycin 500 mg four times daily × 14 days (if tetracycline contraindicated — e.g., pregnancy)
  • Sexual contacts must be traced and treated
  • Topical antibiotics are inadequate alone

Trachoma

Etiology: C. trachomatis serovars A, B, Ba, C. Leading infectious cause of preventable blindness worldwide (endemic in sub-Saharan Africa, Middle East, South Asia).
WHO SAFE strategy: Surgery (for trichiasis), Antibiotics (azithromycin 20 mg/kg single dose, or doxycycline), Facial cleanliness, Environmental improvement.

Neonatal Conjunctivitis (Ophthalmia Neonatorum)

Conjunctival inflammation within the first month of life; most common infection in neonates (up to 10%).
Causes and timing:
CauseOnset
Chemical (prophylaxis irritation)First few days
N. gonorrhoeaeFirst week
Staphylococci, other bacteriaEnd of first week
Herpes simplex virus (HSV-2)1–2 weeks
Chlamydia trachomatis1–3 weeks
Treatment: Gonococcal → parenteral ceftriaxone + topical antibiotic; Chlamydial → oral erythromycin × 2 weeks; HSV → systemic aciclovir (high-dose IV in neonates).

2. Viral Conjunctivitis

Etiology: Adenovirus causes ~90% of viral conjunctivitis. Highly contagious; survives on dry surfaces for weeks; spread by contact with ocular/respiratory secretions. Other agents: enterovirus, coxsackievirus, HSV, varicella-zoster, molluscum contagiosum.
Clinical variants:
FormSerovarsKey Features
Non-specific acute follicular conjunctivitisMultiple adenovirus serovarsMost common; mild; bilateral; upper respiratory symptoms
Pharyngoconjunctival fever (PCF)Ad 3, 4, 7Prominent sore throat; keratitis in ~30%
Epidemic keratoconjunctivitis (EKC)Ad 8, 19, 37Most severe; keratitis in ~80%; photophobia marked; subepithelial infiltrates; pseudomembranes
Acute haemorrhagic conjunctivitisEnterovirus 70, Coxsackievirus A24Tropical; rapid onset; marked conjunctival haemorrhage; resolves 1–2 weeks
HSV conjunctivitisHSV-1/2Unilateral; follicular; associated skin vesicles
Molluscum-associatedPoxvirusChronic follicular; look for lid margin molluscum lesions
Diagnosis: Clinical. PCR for specific viruses if needed. Pseudomembranes and subepithelial infiltrates distinguish EKC.
Treatment:
  • Mostly supportive (lubricants, cold compresses, antihistamines for discomfort)
  • Topical povidone-iodine (0.5–1%) has shown benefit in reducing viral load and duration
  • Short courses of topical steroids for significant subepithelial infiltrates reducing vision in EKC (but may prolong viral shedding)
  • Topical aciclovir for HSV conjunctivitis
  • Hygiene measures are critical to prevent spread (avoid touching eyes, no shared towels, handwashing)

3. Allergic Conjunctivitis

Pathophysiology: Type I (IgE-mediated) hypersensitivity with mast cell degranulation; eosinophil recruitment. Itching is the cardinal symptom.

Forms:

a) Seasonal/Perennial Allergic Conjunctivitis (SAC/PAC)
  • SAC: triggered by seasonal allergens (pollen, grass)
  • PAC: perennial allergens (house dust mite, animal dander)
  • Bilateral itching, watering, mild papillary reaction, chemosis
  • Treatment: topical antihistamines (olopatadine, ketotifen), mast cell stabilizers (sodium cromoglicate, nedocromil), combination agents; allergen avoidance
b) Vernal Keratoconjunctivitis (VKC)
  • Young males in hot climates; seasonal exacerbations
  • Superior giant papillae ("cobblestoning") on upper tarsal conjunctiva; limbal papillae with Horner-Trantas dots (eosinophil aggregates)
  • Mucoid "ropy" discharge
  • Shield ulcer on upper cornea (complication)
  • Treatment: mast cell stabilizers, topical steroids (short courses), topical cyclosporin 1–2%, supratarsal steroid injection; cold compresses
c) Atopic Keratoconjunctivitis (AKC)
  • Adults with atopic dermatitis
  • Preferential inferior palpebral involvement (vs. superior in VKC)
  • Cicatricial changes, symblepharon, forniceal shortening possible
  • Horner-Trantas dots can also appear
  • Treatment: similar to VKC; systemic immunosuppression may be needed for severe cases
d) Giant (Mechanical) Papillary Conjunctivitis
  • Associated with contact lens wear, ocular prostheses, exposed sutures
  • Giant papillae on upper tarsal conjunctiva
  • Treatment: remove/replace offending object; lubricants; mast cell stabilizers
e) Contact Allergic Blepharoconjunctivitis
  • Type IV (delayed) hypersensitivity to topical medications, preservatives, cosmetics
  • Lid erythema + inferior conjunctival follicles/papillae
  • Treatment: identify and eliminate allergen; short-course topical steroid

DIAGNOSTICS — GENERAL APPROACH

InvestigationIndication
Gram stain of scrapingsSuspected gonococcal/meningococcal; neonatal conjunctivitis
Giemsa stainSuspected chlamydial (intracytoplasmic inclusions)
PCR/NAATChlamydial, HSV, adenoviral confirmation
Culture (chocolate agar/Thayer-Martin)N. gonorrhoeae
Direct immunofluorescenceChlamydia (~90% sensitivity)
Conjunctival scraping cytologyEosinophils → allergic; mononuclear cells → viral; PMNs → bacterial
Thyroid functionSuperior limbic keratoconjunctivitis
Biopsy/impression cytologyKeratinization, neoplasia, pemphigoid

DYSTROPHIC (DEGENERATIVE) DISEASES OF THE CONJUNCTIVA

1. Pinguecula

Definition: A yellowish-white, slightly elevated, triangular deposit in the interpalpebral bulbar conjunctiva adjacent to the limbus (nasally more than temporally). It does not extend onto the cornea.
Pathogenesis: Actinic (UV) damage and chronic dryness cause elastotic degeneration of subepithelial stromal collagen with accumulation of abnormal, curled elastic-like fibres (elastotic material). Associated with chronic UV exposure (outdoor workers, equatorial regions), dry/dusty environments, and aging.
Histology: Elastotic (basophilic) degeneration of collagen fibres in the substantia propria; overlying epithelium may be thinned.
Clinical features:
  • Usually asymptomatic; cosmetically noticeable
  • Pingueculitis — acute inflammation of the lesion (redness, irritation) due to surface dryness or UV exposure
  • Rarely progresses to pterygium
Treatment:
  • Observation in most cases
  • Lubricants ± short course topical steroid for pingueculitis
  • Excision for cosmetic reasons or significant irritation (low recurrence rate)
  • Thermal laser ablation

2. Pterygium

Definition: A triangular fibrovascular subepithelial ingrowth of degenerative bulbar conjunctival tissue that crosses the limbus and encroaches onto the cornea, invading Bowman's layer. Typically develops nasally.
Pathogenesis: Same UV-related elastotic degeneration as pinguecula, but with angiogenic activation enabling corneal invasion. Familial tendency. Histologically similar to pinguecula.
Pseudopterygium differs: adhesion of conjunctival band to compromised cornea following chemical burns, corneal ulcers, or cicatrizing conjunctivitis — not a true degeneration.
Clinical features:
  • Symptoms: Most small lesions are asymptomatic. Irritation and grittiness from "dellen" effect (localized tear film disruption at the advancing edge). Vision affected when the visual axis is obscured or astigmatism induced.
  • Signs: Triangular, vascularized, wing-shaped lesion with:
    • Cap — grey zone of Bowman layer dissolution ahead of the advancing head
    • Head — elevated leading edge on the cornea
    • Body — vascular tissue on the sclera
    • Stocker line (iron deposition at the advancing edge of the head)
Treatment:
  • Conservative: lubricants, UV protection (sunglasses), topical steroids for inflammation
  • Surgical excision indicated for:
    • Encroachment toward visual axis
    • Induced astigmatism
    • Persistent symptoms
    • Cosmesis
  • Recurrence is a major problem after simple excision (~30–80%)
  • Anti-recurrence strategies:
    • Conjunctival autograft (preferred, recurrence ~5–10%)
    • Amniotic membrane transplantation
    • Adjunctive mitomycin C (topical or subconjunctival)
    • Beta-irradiation (now less used)

3. Conjunctival Concretions

Small, yellowish deposits of inspissated secretions in the fornices or palpebral conjunctiva; common in elderly; generally asymptomatic unless superficial (may cause foreign body sensation); treated by simple evacuation with a needle if symptomatic.

4. Conjunctivochalasis

Redundant, loose bulbar conjunctival tissue (between the globe and lower lid) causing epiphora, foreign body sensation, and dry eye symptoms. Treatment: lubricants; surgical resection in refractory cases.

5. Retention (Epithelial Inclusion) Cysts

Translucent, thin-walled cysts arising from buried conjunctival epithelium after surgery or trauma. Asymptomatic unless large; treated by excision or needle aspiration.

Summary Comparison: Pinguecula vs. Pterygium

FeaturePingueculaPterygium
LocationBulbar conjunctiva, near limbusCrosses limbus onto cornea
Corneal involvementNoYes (invades Bowman layer)
AppearanceYellowish elevated depositTriangular fibrovascular ingrowth
Vision affectedNoYes (astigmatism, axis obscuring)
HistologyElastotic collagen degenerationSame + angiogenesis
Recurrence after excisionLowHigh (up to 80% simple excision)
Primary treatmentObservation/lubricantsSurgical excision + conjunctival autograft

— Kanski's Clinical Ophthalmology: A Systematic Approach, 10th Edition (Elsevier, 2023)
This is a shared conversation. Sign in to Orris to start your own chat.